VJOncology is committed to improving our service to you

ESMO 2017 | Carboplatin’s future in breast cancer treatment

VJOncology is committed to improving our service to you

Sibylle Loibl

The addition of carboplatin to chemotherapy has shown promise in the treatment of triple-negative breast cancer. Sibylle Loibl, MD, PhD, from the University of Frankfurt, Frankfurt, Germany talks to us about her hopes for this agent, discussing a previous study, the Brightness trial (NCT02032277), which demonstrated the efficacy of carboplatin. This interview was recorded at the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter